Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2016, Article ID 9796768, 6 pages
http://dx.doi.org/10.1155/2016/9796768
Research Article

Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections

1Division of Pulmonary, Allergy, and Critical Care Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA 17033, USA
2Division of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute and Medical Center, Seattle, WA 98104, USA

Received 26 February 2016; Revised 1 June 2016; Accepted 13 June 2016

Academic Editor: Richard Booton

Copyright © 2016 Jason R. McClune et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Christopoulou-Aletra and N. Papavramidou, “‘Empyemas’ of the thoracic cavity in the Hippocratic corpus,” Annals of Thoracic Surgery, vol. 85, no. 3, pp. 1132–1134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. L. Tobin, J. M. Porcel, J. M. Wrightson, G. W. Waterer, R. W. Light, and Y. C. Lee, “Diagnosis of pleural infection: state-of-the-art,” Current Respiratory Care Reports, vol. 1, no. 2, pp. 101–110, 2012. View at Publisher · View at Google Scholar
  3. T. F. Molnar, “Current surgical treatment of thoracic empyema in adults,” European Journal of Cardio-Thoracic Surgery, vol. 32, no. 3, pp. 422–430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. H.-S. Hofmann, “Modern management of empyema thoracis,” Seminars in Thoracic and Cardiovascular Surgery, vol. 25, no. 4, pp. 287–291, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. G. L. Colice and S. Idell, “Counterpoint: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? No,” Chest, vol. 145, no. 1, pp. 17–20, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. H. E. Davies, R. J. O. Davies, and C. W. H. Davies, “Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010,” Thorax, vol. 65, supplement 2, pp. ii41–ii53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. D. Odell and J. D'Cunha, “Intrapleural therapy in empyema thoracis: a contemporary solution to an age-old problem?” Seminars in Thoracic and Cardiovascular Surgery, vol. 23, no. 4, pp. 257–258, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Farjah, R. G. Symons, B. Krishnadasan, D. E. Wood, and D. R. Flum, “Management of pleural space infections: a population-based analysis,” Journal of Thoracic and Cardiovascular Surgery, vol. 133, no. 2, pp. 346–351.e1, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Finley, J. Clifton, J. M. FitzGerald, and J. Yee, “Empyema: an increasing concern in Canada,” Canadian Respiratory Journal, vol. 15, no. 2, pp. 85–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. F. J. H. Brims, S. M. Lansley, G. W. Waterer, and Y. C. G. Lee, “Empyema thoracis: new insights into an old disease,” European Respiratory Review, vol. 19, no. 117, pp. 220–228, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. G. Grijalva, Y. Zhu, J. P. Nuorti, and M. R. Griffin, “Emergence of parapneumonic empyema in the USA,” Thorax, vol. 66, no. 8, pp. 663–668, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. H. A. Berger and M. L. Morganroth, “Immediate drainage is not required for all patients with complicated parapneumonic effusions,” Chest, vol. 97, no. 3, pp. 731–735, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Hamm and R. W. Light, “Parapneumonic effusion and empyema,” European Respiratory Journal, vol. 10, no. 5, pp. 1150–1156, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. C. J. Wozniak, D. E. Paull, J. E. Moezzi et al., “Choice of first intervention is related to outcomes in the management of empyema,” Annals of Thoracic Surgery, vol. 87, no. 5, pp. 1525–1531, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Bar, D. Stav, G. Fink, A. Peer, T. Lazarovitch, and M. Papiashvilli, “Thoracic empyema in high-risk patients: conservative management or surgery?” Asian Cardiovascular and Thoracic Annals, vol. 18, no. 4, pp. 337–343, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Bhatnagar and N. A. Maskell, “Treatment of complicated pleural effusions in 2013,” Clinics in Chest Medicine, vol. 34, no. 1, pp. 47–62, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. J. P. Corcoran and N. M. Rahman, “Point: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? Yes,” Chest, vol. 145, no. 1, pp. 14–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. N. M. Rahman, N. A. Maskell, A. West et al., “Intrapleural use of tissue plasminogen activator and DNase in pleural infection,” The New England Journal of Medicine, vol. 365, no. 6, pp. 518–526, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. L. Colice, A. Curtis, J. Deslauriers et al., “Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline,” Chest, vol. 118, no. 4, pp. 1158–1171, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. N. A. Maskell, C. W. H. Davies, A. J. Nunn et al., “U.K. Controlled trial of intrapleural streptokinase for pleural infection,” The New England Journal of Medicine, vol. 352, no. 9, pp. 865–874, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Thommi, J. C. Shehan, K. L. Robison, M. Christensen, L. A. Backemeyer, and M. T. McLeay, “A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions,” Respiratory Medicine, vol. 106, no. 5, pp. 716–723, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Bouros, S. Schiza, N. Tzanakis, G. Chalkiadakis, J. Drositis, and N. Siafakas, “Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double-blind study,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 1, pp. 37–42, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Bouros, S. Schiza, G. Patsourakis, G. Chalkiadakis, P. Panagou, and N. M. Siafakas, “Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 1, pp. 291–295, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Cameron and H. R. Davies, “Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD002312, pp. 1–22, 2008. View at Google Scholar · View at Scopus
  25. F. Piccolo, N. Pitman, R. Bhatnagar et al., “Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection: an effective and safe alternative to surgery,” Annals of the American Thoracic Society, vol. 11, no. 9, pp. 1419–1425, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Abu-Daff, D. E. Maziak, D. Alshehab et al., “Intrapleural fibrinolytic therapy (IPFT) in loculated pleural effusions-analysis of predictors for failure of therapy and bleeding: a cohort study,” BMJ Open, vol. 3, no. 2, Article ID e001887, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. A. H. Diacon, J. Theron, M. M. Schuurmans, B. W. Van de Wal, and C. T. Bolliger, “Intrapleural streptokinase for empyema and complicated parapneumonic effusions,” American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 1, pp. 49–53, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. H. E. Davies, A. Rosenstengel, and Y. C. Lee, “The diminishing role of surgery in pleural disease,” Current Opinion in Pulmonary Medicine, vol. 17, no. 4, pp. 247–254, 2011. View at Google Scholar
  29. J. A. Shin, Y. S. Chang, T. H. Kim et al., “Surgical decortication as the first-line treatment for pleural empyema,” The Journal of Thoracic and Cardiovascular Surgery, vol. 145, no. 4, pp. 933–939.e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. D. Taylor and B. D. Kozower, “Surgical spectrum in the management of empyemas,” Thoracic Surgery Clinics, vol. 22, no. 3, pp. 431–440, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. N. M. Rahman, B. C. Kahan, R. F. Miller, F. V. Gleeson, A. J. Nunn, and N. A. Maskell, “A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection,” Chest, vol. 145, no. 4, pp. 848–855, 2014. View at Publisher · View at Google Scholar · View at Scopus